Skip to main content
. 2014 Dec 5;6(1):144–158. doi: 10.18632/oncotarget.2670

Table 2. Immunopositivity of CIP2A and Oct4 expression in head and neck squamous cell carcinoma (HNSCC) patient samples.

CIP2A Oct4 Oct4 and CIP2A Co-expression
n 52 52 52
Positive 43/52 19/52 19/52
% 82, 7 36, 5 36, 5